Effect of inclisiran, the siRNA against PCSK9, on platelets, immune cells and immunological biomarkers - a pre-specified analysis from ORION-1.
Ulf Landmesser, Arash Haghikia, LA Leiter, R. Wright, David Kallend, P. Wijngaard, Robert M. Stoekenbroek, Jjp Kastelein, Kausik K. Ray
Topics & Concepts
PCSK9PlateletImmune systemImmunologyMedicineCancer researchBiologyVirologyMolecular biologyCholesterolInternal medicineLDL receptorLipoproteinAtherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular HealthAdipokines, Inflammation, and Metabolic Diseases